Odyssey of trefoil factors in cancer: Diagnostic and therapeutic implications.


Journal

Biochimica et biophysica acta. Reviews on cancer
ISSN: 1879-2561
Titre abrégé: Biochim Biophys Acta Rev Cancer
Pays: Netherlands
ID NLM: 9806362

Informations de publication

Date de publication:
04 2020
Historique:
received: 10 02 2020
revised: 01 04 2020
accepted: 01 04 2020
pubmed: 17 4 2020
medline: 22 7 2020
entrez: 17 4 2020
Statut: ppublish

Résumé

Trefoil factors 1, 2, and 3 (TFFs) are a family of small secretory molecules involved in the protection and repair of the gastrointestinal tract (GI). TFFs maintain and restore epithelial structural integrity via transducing key signaling pathways for epithelial cell migration, proliferation, and invasion. In recent years, TFFs have emerged as key players in the pathogenesis of multiple diseases, especially cancer. Initially recognized as tumor suppressors, emerging evidence demonstrates their key role in tumor progression and metastasis, extending their actions beyond protection. However, to date, a comprehensive understanding of TFFs' mechanism of action in tumor initiation, progression and metastasis remains obscure. The present review discusses the structural, functional and mechanistic implications of all three TFF family members in tumor progression and metastasis. Also, we have garnered information from studies on their structure and expression status in different organs, along with lessons from their specific knockout in mouse models. In addition, we highlight the emerging potential of using TFFs as a biomarker to stratify tumors for better therapeutic intervention.

Identifiants

pubmed: 32298747
pii: S0304-419X(20)30026-3
doi: 10.1016/j.bbcan.2020.188362
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Biomarkers, Tumor 0
Oncogene Proteins 0
Trefoil Factors 0
Tumor Suppressor Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

188362

Subventions

Organisme : NCI NIH HHS
ID : R44 CA224619
Pays : United States
Organisme : NCI NIH HHS
ID : R43 CA235984
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA200466
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA210240
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA217798
Pays : United States

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Rahat Jahan (R)

Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, NE, 68198, USA.

Ashu Shah (A)

Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, NE, 68198, USA.

Sophia G Kisling (SG)

Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, NE, 68198, USA.

Muzafar A Macha (MA)

Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, NE, 68198, USA; Department of Otolaryngology-Head & Neck Surgery, University of Nebraska Medical Center, NE, 68198, USA; Department of Biotechnology, Central University of Kashmir, Ganderbal, Jammu and Kashmir, India -191201.

Sarah Thayer (S)

Division of Surgical Oncology, Department of Surgery, University of Nebraska Medical Center, NE, 68198, USA; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, NE, 68198, USA.

Surinder K Batra (SK)

Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, NE, 68198, USA; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, NE, 68198, USA; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, NE 68198, USA. Electronic address: sbatra@unmc.edu.

Sukhwinder Kaur (S)

Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, NE, 68198, USA. Electronic address: skaur@unmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH